9-hydroxy-10,12,15-octadecatrienoic acid: structure given in first source; RN given refers to (S-(E,Z,Z))-isomer; cpd without isomeric designation not avail 1/90
9(S)-HOTrE : A 9-HOTrE consisting of (10E,12Z,15Z)-octadecatrienoic acid in which the 9-hydroxy group has S-configuration.
ID Source | ID |
---|---|
PubMed CID | 6439873 |
CHEBI ID | 80447 |
SCHEMBL ID | 8263230 |
MeSH ID | M0172107 |
Synonym |
---|
9s-hydroxy-10e,12z,15z-octadecatrienoic acid |
9s-hotre |
LMFA02000024 |
(9s)-(10e,12z,15z)-9-hydroxyoctadecatri-10,12,15-enoic acid |
9(s)-hot |
9(s)-hotre |
(9s,10e,12z,15z)-9-hydroxyoctadeca-10,12,15-trienoic acid |
10-12-15-octadecatrienoic acid, 9-hydroxy-, (s-(e,z,z))- |
9-hydroxy-10,12,15-octadecatrienoic acid |
9-oh-10,12,15-odta |
(10e,12z,15z)-9-oh-10,12,15-odta |
89886-42-0 |
(9s,10e,12z,15z)-9-hydroxyoctadecatrienoic acid |
CHEBI:80447 |
SCHEMBL8263230 |
10,12,15-octadecatrienoic acid, 9-hydroxy-, (9s,10e,12z,15z)- |
RIGGEAZDTKMXSI-MEBVTJQTSA-N |
10,12,15-octadecatrienoicacid,9-hydroxy-,(9s,10e,12z,15z)- |
Q27149496 |
9(s)-hydroxy-10e,12z,15z-octadecatrienoic acid |
sr-01000946951 |
SR-01000946951-1 |
9(s)-hydroxy-10(e),12(z),15(z)-octadecatrienoic acid |
PD020943 |
DTXSID601345732 |
AKOS040756087 |
Role | Description |
---|---|
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
9-HOTrE | A hydroxyoctadecatrienoic acid that consists of 10E,12Z,15Z-octadecatrienoic acid bearing an additional 9-hydroxy substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.69) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |